Landi D. Continuation of natalizumab versus interruption is associated with lower risk of relapses during pregnancy and postpartum in women with MS. Abstract 338. ECTRIMS 2019, 11-13 sept 2019, Stockholm, Zweden.
Bijna kwart miljoen mensen met recept van neuroloog
jan 2019 | Bewegingsstoornissen, Epilepsie, Neuro-vasculair, Overig